Harvard Business Review

AUGUST 8, 2018

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. In another supplementary analysis, we used the rankings of finance departments in business schools.

Influence 9

Influence Education Pharmaceuticals Finance 9

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. For both public and private insurers, a long-term view should be feasible.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 20, 2016

According to the World Trade Organization, international trade this year will grow at its slowest pace since 2007. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. at the forefront. This year, for example, the U.S.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 14

Apparel Pharmaceuticals Finance Licensing 14

Harvard Business Review

NOVEMBER 10, 2017

Despite the amount they invest in corporate learning, organizations continue to struggle to connect these programs with the day-to-day work of strategy execution. Like many parts of large organizations, they are captive to a rich and debilitating status quo. Learning departments are frequently part of the problem.

Skills 8

Skills Agility Learning-by-Doing Content 8

Harvard Business Review

NOVEMBER 9, 2011

What role does he or she play in the organization? Only two of the 37 organizations we studied had appointed more than two COOs in their history; in 27, the current COOs had only one predecessor; and in the remaining eight corporations, the incumbents were the companies' first COOs. Does your company have a COO today?

COO 11

COO Sample Telecommunications Automotive 11

Harvard Business Review

AUGUST 29, 2011

There's a sense that a woman is just working until she gets married, [that] she is not a long-term resource," said one senior finance professional. IWIN makes Infosys a female-friendly environment by identifying the stress points at which women tend to leave the organization and creating policies that help them deal with those stresses.

Stress 13

Stress Human Resources Pharmaceuticals Sharpe 13

Harvard Business Review

SEPTEMBER 5, 2016

The concept is fairly straightforward: The parties define the result up front, agree on a baseline, work out how confident the organization is in delivering the result, and then specify the expectation and payment in the contract. Samuel Castro. Paying for results is in vogue. ” Health care. When PbR Doesn’t Work.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. .” ”

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

AUGUST 6, 2015

I made a career switch seven years ago, when I went from working as a reporter at the Financial Times , where I covered health care in the United States, to consulting — advising CEOs in the pharmaceutical industry on thought leadership and articulating their corporate strategies. Consider the legal field. Execute fast.

Career 8

Career Skills Health Care Pharmaceuticals 8

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. The failure stemmed from resistance in the U.S. The failures continue. What builds management perspectives?

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

MAY 26, 2014

Accountable Care Organization (ACO) models in both the private and the public sectors are rewarding providers for lowering the overall costs of care and keeping patients healthy. Top-tier thinkers from data science, business, finance, and the digital world are coming together to find new solutions.

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

APRIL 5, 2012

This allowed the business to grow sales productivity by 7 percent and give back a budgeted $2 million for additional headcount — the productivity improvements allowed the sales organization to meet growth goals without adding people. Market potential adds insight to sales planning. Some approaches include: • Buy existing data.

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

AUGUST 23, 2018

By placing teens in subsidized jobs with government agencies, nonprofit organizations, and private employers, these programs were initially seen as a way to increase family earnings, improve future employment prospects, and reduce crime. Many large U.S.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

MAY 15, 2013

While there is universal agreement that (1) it exists, and (2) that it plays a crucial role in shaping behavior in organizations, there is little consensus on what organizational culture actually is, never mind how it influences behavior and whether it is something leaders can change. Culture is a process of "sense-making" in organizations.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

SEPTEMBER 13, 2011

Most organizations take the same stance. But only athletic events produce clear winners and losers in the short-term — and most organizations are not actively engaged in those. I've always been a big believer in using results as the differentiator between success and failure. You either achieve your goals or you don't.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

MARCH 24, 2011

sense, it entails a potentially disastrous failure of the imagination, an inability to appreciate all the exigencies the client confronts in trying to actually get something done, much less changed, within his organization. Among McKinsey's biggest clients in the 1990s were pharmaceuticals and financial-services companies.

McKinsey 13

McKinsey Consultative Waterman Intellectual Capital 13

Harvard Business Review

FEBRUARY 4, 2013

Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance. Major questions remain over how some of this systems thinking can be operationalized across big, complex organizations. Breakthrough Access. Breakthrough involves a shift to new types of impact investment.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

APRIL 23, 2012

Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. By any reasonable definition, pharmaceutical salespeople are absolutely salespeople. Pharmaceutical companies measure territory sales results.

Pharmaceuticals 12

Pharmaceuticals Banking Objective Incentives 12

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. Generally speaking, these multi-company issues have arisen from bad acts by individuals in the middle of the organization and do not appear to have been directed from the top of the corporation.

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. From a historical perspective, the idea that managers in organizations have a single, dominant duty — to achieve or maximize economic returns — is a striking development. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Mills Scofield

NOVEMBER 11, 2014

This is taken from The Intercollegiate Finance Journal (IFJ) is an undergraduate student-run journal about how current finance, economics, business and technology issues affect students'' lives. Please support this organization to let our youth''s voices be heard! The IFJ can be found on LinkedIn , Facebook , and Twitter.

Finance 131

Finance Incentives Education Pharmaceuticals 131

Harvard Business Review

JANUARY 26, 2016

and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields. That is the one area where “intelligent organizations” differ most from others. We received 236 responses from 21 industries in U.S. They had an average of 6.3

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

MARCH 6, 2014

Indeed, should this have not crossed your mind, the PLoS authors tie their findings to past behavior by the tobacco and pharmaceutical industries. Narrative, bias, and focus, provide an overwhelming rationale to file the story under “malfeasance” with a note to disregard the legitimacy of any data produced by that industry’s funding.

Peer Review 8

Peer Review Review Industry Wilde 8